KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tenet Healthcare (THC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $1.2 billion.

  • Tenet Healthcare's Cost of Revenue rose 1075.07% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.5 billion, marking a year-over-year increase of 69.01%. This contributed to the annual value of $4.5 billion for FY2025, which is 69.01% up from last year.
  • Tenet Healthcare's Cost of Revenue amounted to $1.2 billion in Q4 2025, which was up 1075.07% from $1.1 billion recorded in Q3 2025.
  • Over the past 5 years, Tenet Healthcare's Cost of Revenue peaked at $1.2 billion during Q4 2023, and registered a low of $942.0 million during Q1 2022.
  • Over the past 5 years, Tenet Healthcare's median Cost of Revenue value was $1.1 billion (recorded in 2023), while the average stood at $1.1 billion.
  • Per our database at Business Quant, Tenet Healthcare's Cost of Revenue tumbled by 1212.69% in 2022 and then skyrocketed by 1602.97% in 2023.
  • Quarter analysis of 5 years shows Tenet Healthcare's Cost of Revenue stood at $1.0 billion in 2021, then rose by 0.29% to $1.0 billion in 2022, then grew by 15.89% to $1.2 billion in 2023, then decreased by 9.78% to $1.1 billion in 2024, then rose by 10.75% to $1.2 billion in 2025.
  • Its Cost of Revenue was $1.2 billion in Q4 2025, compared to $1.1 billion in Q3 2025 and $1.1 billion in Q2 2025.